In vivo 3D MRI staining of mouse brain after subcutaneous application of MnCl2

Takashi Watanabe1, Oliver Natt, Susann Boretius

  • 1Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut für biophysikalische Chemie, Göttingen, Germany.

Insights

Manganese chloride (MnCl2) injected into mice enhances MRI signals in the brain by affecting water relaxation times. This manganese (Mn2+) contrast highlights brain structures and may aid in studying neurological conditions.

Area of Science:

  • Neuroimaging
  • Biomedical Engineering
  • Pharmacology

Background:

  • Magnetic Resonance Imaging (MRI) is a crucial tool for visualizing brain structure and function.
  • Contrast agents can enhance MRI signal but require careful consideration of their distribution and effects.
  • Paramagnetic ions, like manganese (Mn2+), can alter water proton relaxation times, influencing MRI signal intensity.

Purpose of the Study:

  • To investigate the in vivo effects of systemically administered manganese chloride (MnCl2) on murine brain MRI.
  • To assess the distribution and temporal dynamics of Mn2+ in the brain using T1-weighted MRI.
  • To explore the potential of Mn2+ as an MRI contrast agent for neuroimaging and phenotyping.

Main Methods:

  • T1-weighted 3D gradient-echo MRI was performed on mice (N=5) at 2.35 T with 120 microm isotropic resolution.
  • Mice received subcutaneous injections of MnCl2 (20 mg/kg).
  • Brain imaging was conducted at various time points (6-48 hours) post-injection to track Mn2+ distribution.

Main Results:

  • Spatially distinct signal increases were observed in the murine brain 6-48 hours after MnCl2 administration.
  • Enhanced signal was initially prominent in structures lacking a blood-brain barrier (BBB), such as the choroid plexus, pituitary, and pineal glands.
  • Within 24 hours, Mn2+ contrast highlighted the olfactory bulb, inferior colliculi, cerebellum, and hippocampal CA3 subfield, suggesting neuronal uptake and axonal transport.

Conclusions:

  • Systemic administration of MnCl2 acts as an effective in vivo MRI contrast agent in the murine brain.
  • The observed Mn2+ distribution suggests both passive diffusion into areas without a BBB and active neuronal uptake.
  • Mn2+ enhanced MRI may serve as a valuable tool for phenotyping mutant mice with central nervous system alterations.

Related Concept Videos